In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 6, 2007, Pages 1185-1189

  Cafini, F ^a   Aguilar, L ^a   Gonzalez N ^a   Gimenez M J ^a   Torrico, M ^a   Alou, L ^a   Sevillano, D ^a   Vallejo, P ^a   Prieto, J ^a  

^a SCHOOL OF MEDICINE   (Spain)

Author keywords

Enterococci; Killing curves; Protein binding; Staphylococci; Streptococci

Indexed keywords

DAPTOMYCIN; HUMAN ALBUMIN; LEVOFLOXACIN; METICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; INOCULATION; MAXIMUM PLASMA CONCENTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; PROTEIN BINDING; SERUM; STREPTOCOCCUS PNEUMONIAE;

AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; SERUM; SERUM ALBUMIN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 34447104801     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm078     Document Type: Article

References (10)

1. Pérez-Trallero E, Marimón JM, Gonzalez A et al. Genetic relatedness of recently collected Spanish respiratory tract Streptococcus pneumoniae isolates with reduced susceptibility to amoxicillin. Antimicrob Agents Chemother 2003; 47: 3637-9.
2. Asensio A, Cantón R, Vaque J et al. Nosocomial and community-acquired meticillin-resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993-2003). J Hosp Infect 2006; 63: 465-71.
3. Torres C, Escobar S, Portillo A et al. Detection of clonally related vanB2-containing Enterococcus faecium strains in two Spanish hospitals. J Med Microbiol 2006; 55: 1237-43.
4. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Supplement M100-S13 NCCLS, Wayne, PA, USA, 2003.
5. Walsh TR, Bolmstrom A, Qwamstrom A et al. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001; 39: 2439-44.
6. Dvorchik BH, Brazier D, DeBruin MF et al. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother 2003; 47: 1318-23.
7. Dykhuizen RS, Harvey G, Stephenson N et al. Protein binding and serum bactericidal activities of vancomycin and teicoplanin. Antimicrob Agents Chemother 1995; 39: 1842-7.
8. 2+ and albumin on these drugs. Antimicrob Agents Chemother 1991; 35: 1710-6.
9. Moellering RC, Eliopoulos GM. Principles of anti-infective therapy. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett Principles and Practice of Infectious Diseases-Sixth Edition. Philadelphia: Elsevier Churchill Livingstone, 2005; 242-53.
10. DeRyke CA, Sutherland C, Zhang B et al. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species. Antimicrob Agents Chemother 2006; 50 3529-34.